BioNTech SE (BNTX) Depreciation & Amortization (CF) (2018 - 2025)
BioNTech SE's Depreciation & Amortization (CF) history spans 8 years, with the latest figure at $57.7 million for Q2 2025.
- On a quarterly basis, Depreciation & Amortization (CF) rose 7.43% to $57.7 million in Q2 2025 year-over-year; TTM through Dec 2025 was $102.8 million, a 67.98% decrease, with the full-year FY2024 number at $318.4 million, up 61.38% from a year prior.
- Depreciation & Amortization (CF) hit $57.7 million in Q2 2025 for BioNTech SE, up from $45.0 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for BNTX hit a ceiling of $176.7 million in Q4 2024 and a floor of $15.68 in Q1 2021.
- Historically, Depreciation & Amortization (CF) has averaged $47.7 million across 5 years, with a median of $38.5 million in 2022.
- The widest YoY moves for Depreciation & Amortization (CF): up 199570464.14% in 2021, down 100.0% in 2021.
- Tracing BNTX's Depreciation & Amortization (CF) over 5 years: stood at $29.7 million in 2021, then dropped by 0.52% to $29.6 million in 2022, then surged by 186.56% to $84.8 million in 2023, then surged by 108.47% to $176.7 million in 2024, then tumbled by 67.34% to $57.7 million in 2025.
- Business Quant data shows Depreciation & Amortization (CF) for BNTX at $57.7 million in Q2 2025, $45.0 million in Q1 2025, and $176.7 million in Q4 2024.